This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,815.46 firm-fixed-price delivery order contract is for the supply of the HIV medication Biktarvy, with a period of performance through May 14, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award, valued at $38,483.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Biktarvy 50-200-25 mg tablet, a HIV medication. The contract is a firm-fixed price delivery order with an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This federal contract award, valued at $18,060.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,022.25 delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets, a prescription medication, with a period of performance through April 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,696.76, is for the delivery of Biktarvy 50-200-25 mg tablets, which are used to treat HIV. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 29, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
This federal contract award for $29,712.57 was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a prescription medication used to treat HIV infection. The contract has an ultimate completion date of March 11, 2024. The contract was awarded on March 8, 2024 and is a firm fixed-price delivery order. No set-aside was used for this award. AmerisourceBergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $12,500.73 firm fixed price delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a brand name HIV medication, to support military treatment programs and facilities. The award is associated with a single-award indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp that has a...
This federal contract award, valued at $19,773.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of the prescription medication Biktarvy, a treatment for human immunodeficiency virus (HIV). The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. Additionally, AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $44,018.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a prescription medication used in the treatment of HIV. The contract is a Firm Fixed Price Delivery Order that runs through July 17, 2024. It is not associated with any set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,885.65 delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV. The contract is a firm fixed-price delivery order with a completion date of December 29, 2022. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999...